Project Grant HT94252411069
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
East Orange, NJ 07018, USA
Similar Awards
The federal Project Grant award of $1,225,245.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research initiative titled "CARDIOVASCULAR RISK PROFILING OF DEPLOYMENT-RELATED RESPIRATORY DISEASE: A TRANSLATIONAL APPROACH" at The Ohio State University. The research project aims to investigate cardiovascular risk factors associated with deployment-related respiratory diseases, with the goal of developing...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...
The federal Project Grant award of $5,954,349.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The award was made to Virginia Commonwealth University (VCU), which is collaborating with the Palo Alto Veterans Institute for Research (Pavir) and the Richmond Institute for...
This Project Grant award of $2,377,839.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding evidence-based research to predict cardiovascular risk in immune-mediated inflammatory diseases. The grant was awarded on June 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a leading academic medical center and research institution. Over the performance period of June 1, 2025 to May 31, 2029, this funding will...
The Department of Defense's Defense Health Agency awarded a $2,264,623 Project Grant to Vanderbilt University Medical Center (VUMC) on May 1, 2025 under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "TOXICANT-MEDIATED PULMONARY HYPERTENSION IN SOUTHWEST ASIA VETERANS", will support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research aims to investigate medical...
The U.S. Defense Health Agency awarded a $2,916,605 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Boston VA Research Institute, Inc. (BVARI) on September 30, 2023. The 4-year award, titled "LONG-TERM PSYCHOLOGICAL AND PHYSICAL HEALTH OUTCOMES FOLLOWING MILITARY DEPLOYMENT: THE VETERANS AFTER-DISCHARGE LONGITUDINAL REGISTRY (PROJECT VALOR)", will fund BVARI's research to investigate risk factors, prevention, and...
The federal Project Grant award of $5,099,737.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a myeloid-targeted novel therapeutic for glomerular diseases. The award, with a performance period from July 1, 2025 to June 30, 2029, was granted to 149 Bio LLC, a for-profit organization located in Miami, Florida. The funded research aims to transform healthcare for military service members, veterans, and the broader public...
The Defense Health Agency awarded a $974,043 Project Grant to Cedars-Sinai Medical Center under the Military Medical Research and Development (CFDA 12.420) program. The grant supports early cardiac biomarker research focused on inflammation and remodeling in Duchenne muscular dystrophy. This 4-year award, running from September 1, 2025 to August 31, 2029, will fund innovative biomedical investigations at Cedars-Sinai aimed at transforming healthcare for military service members and the broader...
The Department of Defense's Defense Health Agency has awarded a $4,876,076 Project Grant to Washington University to develop a novel point-of-care multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. This research falls under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The grant has a performance...
The U.S. Defense Health Agency awarded a $777,659 Project Grant to the Children's Research Institute in Washington, D.C. under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to transform healthcare for military service members, veterans, and the public, with a focus on innovative research addressing critical health challenges. Specifically, the award will fund the "Use of ProResolution and Restorative Pharmacology...